Pancreatic Cancer Research - Symptoms, Causes, Treatment, Information

Pancreatic Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Pancreatic Cancer, including details on symptoms, causes, treatment, information.


Pancreatic Cancer Research Today

Home

View Latest Issue

Information About Pancreatic Cancer

Books on Pancreatic Cancer

Advertising in Research Today

View Other Research Today Publications



Volume 3 (2006), Issue 8 (August)

  1. Immunomodulatory impact of interferon-alpha in combination with chemoradiation of pancreatic adenocarcinoma (CapRI).
    Cancer Immunol Immunother, 55(11): 1396-405. [Abstract] [Full-text]
  2. AURKA is one of the downstream targets of MAPK1/ERK2 in pancreatic cancer.
    Oncogene, 25(35): 4831-9. [Abstract] [Full-text]
  3. Decreased expression of eukaryotic initiation factor 3f deregulates translation and apoptosis in tumor cells.
    Oncogene, 25(35): 4923-36. [Abstract] [Full-text]
  4. Randomized phase III trial of gemcitabine plus cisplatin compared with gemcitabine alone in advanced pancreatic cancer.
    J Clin Oncol, 24(24): 3946-52. [Abstract] [Full-text]
  5. Differing molecular pathology of pancreatic adenocarcinoma in Egyptian and United States patients.
    Int J Cancer, 119(6): 1455-61. [Abstract] [Full-text]
  6. Extended pancreatectomy with resection of the celiac axis: the modified Appleby operation.
    Am J Surg, 192(3): 330-5. [Abstract] [Full-text]
  7. Prognostic factors for survival in pancreatic cancer: a population-based study.
    Am J Surg, 192(3): 322-9. [Abstract] [Full-text]
  8. EGF receptor antagonism improves survival in a murine model of pancreatic adenocarcinoma.
    J Surg Res, 135(1): 195-201. [Abstract] [Full-text]
  9. Resection of pancreatic neuroendocrine tumors: results of 70 cases.
    Arch Surg, 141(8): 765-9; discussion 769-70. [Abstract] [Full-text]
  10. Surgery increases survival in patients with gastrinoma.
    Ann Surg, 244(3): 410-9. [Abstract] [Full-text]
  11. Evaluation of imaging-guided core biopsy of pancreatic masses.
    AJR Am J Roentgenol, 187(3): 769-72. [Abstract] [Full-text]
  12. PNC-28, a p53-derived peptide that is cytotoxic to cancer cells, blocks pancreatic cancer cell growth in vivo.
    Int J Cancer, 119(7): 1577-85. [Abstract] [Full-text]
  13. Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer.
    Am J Surg Pathol, 30(9): 1067-76. [Abstract] [Full-text]
  14. The role of paraaortic lymph node involvement on early recurrence and survival after macroscopic curative resection with extended lymphadenectomy for pancreatic carcinoma.
    J Am Coll Surg, 203(3): 345-52. [Abstract] [Full-text]
  15. Sonic hedgehog is an early developmental marker of intraductal papillary mucinous neoplasms: clinical implications of mRNA levels in pancreatic juice.
    J Pathol, 210(1): 42-8. [Abstract] [Full-text]
  16. Fine-needle aspiration of pancreatic serous cystadenoma: cytologic features and diagnostic pitfalls.
    Cancer, 108(4): 239-49. [Abstract] [Full-text]
  17. Intraductal papillary-mucinous neoplasms and mucinous cystic neoplasms of the pancreas differentiated by ovarian-type stroma.
    Surgery, 140(3): 448-53. [Abstract] [Full-text]
  18. Mitochondrial DNA D-loop in pancreatic cancer: somatic mutations are epiphenomena while the germline 16519 T variant worsens metabolism and outcome.
    Am J Clin Pathol, 126(4): 593-601. [Abstract] [Full-text]
  19. Quality of life after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head.
    Br J Surg, 93(9): 1099-107. [Abstract] [Full-text]
  20. A multicenter phase III trial comparing irinotecan-gemcitabine (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic pancreatic cancer.
    Br J Cancer, 95(5): 587-92. [Abstract] [Full-text]
  21. Histone deacetylase inhibitor trichostatin A and proteasome inhibitor PS-341 synergistically induce apoptosis in pancreatic cancer cells.
    Biochem Biophys Res Commun, 348(4): 1245-53. [Abstract] [Full-text]
  22. MUC2 expression is regulated by histone H3 modification and DNA methylation in pancreatic cancer.
    Int J Cancer, 119(8): 1850-7. [Abstract] [Full-text]
Place a permanent text-link or advertisement here for just US$15.

© 2004-2008 Pancreatic Cancer Research Today. All Rights Reserved.



Pancreatic Cancer Research Today Archive:

Volume 1 (2004)
  Issue 1 (September)
  Issue 2 (October)
  Issue 3 (November)
  Issue 4 (December)

Volume 2 (2005)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 3 (2006)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 4 (2007)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 5 (2008)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)



Pancreatic Cancer Books

Handbook of Immunohistochemistry and in situ Hybridization of Human Carcinomas : Molecular Genetics: Liver and Pancreatic Carcinomas (Handbook of Immunohistochemistry ... in Situ Hybridization of Human Carcinomas)

Handbook of Immunohistochemistry and in situ Hybridization of Human Carcinomas : Molecular Genetics: Liver and Pancreatic Carcinomas (Handbook of Immunohistochemistry ... in Situ Hybridization of Human Carcinomas)